EP3110434
UTI-samrunaprótín
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
23.2.2015EP published:
19.9.2018EP application number:
15708411.2
EP translation filed:
19.12.2018Grant published:
15.1.2019EPO information:
European Patent Register
Max expiry date:
22.2.2035Expiry date:
22.2.2027Next due date:
28.2.2027
Title:
UTI FUSION PROTEINS
Timeline
Today
23.2.2015EP application
19.9.2018EP Publication
19.12.2018Translation submitted
15.1.2019Registration published
22.2.2027Expires
Owner
Name:
Takeda GmbHAddress:
Byk-Gulden-Strasse 2, 78467, Konstanz, DE
Name:
Takeda Pharmaceutical Company LimitedAddress:
1-1 Doshomachi 4-chome Chuo-ku, 541-0045, Osaka-shi, Osaka, JP
Inventor
Name:
CHAMBERLAIN, AaronAddress:
San Diego, California, US
Name:
LIU, QiangAddress:
San Diego, California, US
Name:
SCHMIDT, MathiasAddress:
San Diego, California, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201461943617 PDate:
24.2.2014Country:
US
Classification
Categories:
C07K 14/81
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 31.1.2019
Expires: 22.2.2020
Payer: Sigurjónsson & Thor ehf.
Number: 6
Paid: 31.1.2020
Expires: 22.2.2021
Payer: Sigurjónsson & Thor ehf.
Number: 7
Paid: 2.2.2021
Expires: 22.2.2022
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 19.1.2022
Expires: 22.2.2023
Payer: Patice ehf.
Number: 9
Paid: 19.1.2023
Expires: 22.2.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 16.2.2024
Expires: 22.2.2025
Payer: CPA Global (Patrafee) AB
Number: 11
Paid: 21.2.2025
Expires: 22.2.2026
Payer: CPA Global (Patrafee) AB
Number: 12
Paid: 26.2.2026
Expires: 22.2.2027
Payer: CPA Global (Patrafee) AB